Clinical Trials in Philadelphia

Showing 10041-10060 of 17,926 trials

Phase 2 Study of Bevacizumab in Children and Young Adults With NF 2 and Progressive Vestibular Schwannomas

NCT01767792

To determine the hearing response rate at 24 weeks after treatment with bevacizumab for symptomatic vestibular schwannomas (VS) in children and young adults with Neurofibromatosis Type 2 (NF 2).

Neurofibromatosis Type 2Progressive Vestibular Schwannomas

University of Alabama at Birmingham22 participantsStarted May 2013

Los Angeles, California, United States • Washington D.C., District of Columbia, United States • Atlanta, Georgia, United States +9 more locations

COMPLETEDPhase 4< 1 mile

A Multi-Risk Factor Strategy vs a Guideline-Based Approach in Achieving Blood Pressure and Lipid Goals in Hypertensives at Extra Risk

NCT00412113

The purpose of this study is to investigate whether an aggressive multi-risk factor management strategy (Caduet plus therapeutic lifestyle changes (TLC) regimen) will result in greater percentage of patients achieving blood pressure and low density lipoprotein cholesterol (LDL-C) goals compared with a Joint National Committee 7/ National Cholesterol Education Program Adult Treatment Panel III (JNC 7/NCEP ATP III) guideline-based approach (Norvasc plus TLC regimen) after 6 weeks of treatment in primary prevention subjects with hypertension and additional risk factors, including dyslipidemia.

DyslipidemiaHypertension

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.245 participantsStarted Jan 2007

Birmingham, Alabama, United States • Birmingham, Alabama, United States • Birmingham, Alabama, United States +48 more locations

Phase 2 Study of Bevacizumab in Children and Young Adults With NF 2 and Progressive Vestibular Schwannomas

A Multi-Risk Factor Strategy vs a Guideline-Based Approach in Achieving Blood Pressure and Lipid Goals in Hypertensives at Extra Risk

Find Trials by Condition in Philadelphia

Combination Tissue Plasminogen Activator (Tpa) and Dornase Alfa (Dnase) Administration Through Intrapleural Catheters for the Treatment of Loculated or Non-Draining Malignant Pleural Effusions

Pregabalin in the Treatment of Patients With Generalized Anxiety Disorder (GAD).

Use of a Single Dose of Oral Prednisone in the Treatment of Cellulitis

Polysomnography Study Of Pregabalin And Pramipexole Versus Placebo In Patients With Restless Legs Syndrome And Associated Sleep Disturbance

Study of MEDI4736 Monotherapy and in Combination With Tremelimumab Versus Standard of Care Therapy in Patients With Head and Neck Cancer

The Altis® Single Incision Sling System for Female Stress Urinary Incontinence Study

Study to Evaluate Efficacy and Safety of E-101 Solution for Preventing Surgical Site Infections After Colorectal Surgery

Safety of Rivipansel (GMI-1070) in the Treatment of One or More Vaso-Occlusive Crises in Hospitalized Subjects With Sickle Cell Disease

Interactive Technology for Media Literacy Drug Prevention in Community Groups

Comparative Study of Intermittent Catheters and Occurrence of Urinary Tract Infections

Randomized Trial to Assess PO Versus IV Antibiotics

Suprachoroidal Injection of Triamcinolone Acetonide in Subjects With Macular Edema Following Non-Infectious Uveitis

Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Melanoma

Lyrica Dose Response Study With Restless Legs Syndrome (RLS) Patients

Safety, Tolerability, and Pharmacokinetic Study of Pregabalin in Pediatric Patients With Partial Onset Seizures

P4 (Pregabalin for Peripheral Posttraumatic Pain)

Efficacy and Safety of Pregabalin vs Placebo for Generalized Anxiety Disorder (GAD) Symptoms in Subjects Discontinuing Benzodiazepine Treatment and Remaining 6 Weeks on Study Medication, Free From Benzodiazepine Use.

Safety, Tolerability and Efficacy of Rapid Optimization, Helped by NT-proBNP testinG, of Heart Failure Therapies